Digital Therapeutics – Thematic Intelligence

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$1950
Buy Report View Sample

Published: October 31, 2023 Report Code: GDHCHT434-TH

Select Item

Explore actionable trends and insights with the following data sets in the ‘Digital Therapeutics’ report:

  • Market analysis of approved and reimbursed digital therapeutic products by region.
  • Case studies with in-depth insight into some of the most recent and most influential developments in the digital therapeutics theme.
  • Product profiles of disruptive digital therapeutic products across key therapeutic areas.
  • A focused chapter on the key healthcare, technology, macroeconomic, and regulatory trends impacting digital therapeutics, and a review of how these trends will accelerate or hinder the market.
  • Assessment of leaders and disruptors across the key therapeutic areas that digital therapeutics are indicated for.

How is the ‘Digital Therapeutics’ report unique from other reports in the market? The report will equip you to:

  • Understand the key trends accelerating or hindering the digital therapeutics space.
  • Review of leaders and disruptors across the digital therapeutics value chain.
  • Understand recent and influential developments in digital therapeutics.
  • View a regional analysis of the current digital therapeutics market and a breakdown of regulatory and reimbursement pathways for digital therapeutics worldwide.

We recommend this valuable source of information to anyone involved in: 

  • ​Pharma and Biotech Companies/Pharmaceutical Industry Suppliers
  • Consulting and Professional Services (e.g., Investment Companies, Investment Banks, Equity Companies, etc.)
  • Pharma Manufacturers (Innovative, Biotech, Generics, Biosimilars, Rare/Orphan Disease) / Distributors
  • Financial Institutions (Investors in Pharma/Biotech, Pricing Consultancies)/Parallel Trade Organisations
  • Healthcare Organisations/Healthcare technology leaders and Start-ups

To Get a Snapshot of the Digital Therapeutics Thematic Report

Download a Free Report Sample

Digital Therapeutics Thematic Report Overview

Digital therapeutics (DTx) is a segment of solutions within the wider digital health landscape that delivers evidence-based therapeutic interventions to prevent, treat, or manage disease. DTx could be the future of patient-centric healthcare by providing personalized programs to patients anywhere with limited or no medications for some indications. However, a lack of regulatory and reimbursement pathways could hinder the widespread adoption of digital health technologies such as DTx.

The DTx thematic research report discusses emerging healthcare, macroeconomic, technology, and regulatory trends in the digital therapeutics market and predicts future outcomes. It provides insights into the leading players and future disruptors across the value chain. The report covers the opportunities and risks over the foreseeable future for digital therapeutics. It also identifies strategic planners, competitive intelligence professionals, and key stakeholders in the pharmaceutical industry.

Key Trends ·        Healthcare Trends

·        Macroeconomic Trends

·        Technology Trends

·        Regulatory Trends
Key Value Chain Components ·        Cardiovascular

·        Central Nervous System

·        Immunology

·        Metabolic Disorders

·        Musculoskeletal Disorders

·        Oncology

·        Women’s Health
Leading Public Companies ·        Akili

·        Aptar

·        Better Therapeutics

·        DarioHealth

·        Elekta
Leading Private Companies ·        AppliedVR

·        Axena Health

·        BehaVR

·        BfB Labs

·        Big Health
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Digital Therapeutics – Key Trends

The key trends that will influence the digital therapeutics theme over the next 12 to 24 months are classified into four categories:

  • Healthcare Trends: The impact of COVID-19 on the provision of healthcare, personalized treatments, patient empowerment, surge in chronic diseases and mental illness, and increased focus on value-based care are a few healthcare trends that are likely to influence the digital therapeutics market.
  • Technology Trends: Artificial intelligence, immersive technologies, data privacy, interoperability, and gamification are the key technologies expected to strengthen the digital therapeutics theme over the projected period.
  • Macroeconomic Trends: Challenging financial environment, layoffs, and bankruptcy coupled with the shortages of physicians are key trends impacting the digital therapeutics theme at a macroeconomic level. Furthermore, venture capital investment fundings and strategic partnerships between DTx manufacturers and pharmaceutical companies, healthcare providers, and technology companies will influence the digital therapeutics theme.
  • Regulatory Trends: Regulation of DTx in the US and the EU and reimbursement of DTx in the US and the EU are expected to impact the DTx theme over the next few years.

Buy the Full Report for More Insights on the Key Trends Impacting the Digital Therapeutics Theme
Download a Free Sample Report

Digital Therapeutics – Market Analysis

The digital therapeutics thematic analysis provides information on digital therapeutics that are available for use in several regions. These include the digital therapeutics cleared or granted for use by the FDA, reimbursed in European countries such as Germany, the UK, France, and Belgium; and attained regulatory clearance in other regions such as Japan, Australia, and South Korea.

The digital therapeutics market analysis also covers:

  • Product profiles
  • Signals
  • Partnerships
  • Venture financing
  • Mergers and acquisitions
  • Hiring trends
  • Social media trends

Buy the Full Report for the Digital Therapeutics Market Analysis, Download a Free Sample Report

Digital Therapeutics – Value Chain Analysis

The digital therapeutics value chain report focuses on key therapy areas, including cardiovascular, CNS, immunology, metabolic, musculoskeletal, oncology, and women’s health.

Cardiovascular: DTx solutions available in 2023 for cardiovascular diseases are typically indicated for treating patients with hypertension and COPD. These solutions treat patients by modifying patient lifestyles to reduce the severity and symptoms of the disease and deploying Internet of Things (IoT) devices such as blood pressure monitors to track progress.

Digital Therapeutics Value Chain Analysis

Digital Therapeutics Value Chain Analysis

Buy the Full Report for the Digital Therapeutics Value Chain Analysis, Download a Free Sample Report

Digital Therapeutics – Competitive Landscape

The leading companies within the digital therapeutics theme are:

Public Companies: Akili, Aptar, Better Therapeutics, DarioHealth, and Elekta among others are the leading public companies in the digital therapeutics theme.

Private Companies: AppliedVR, Axena Health, BehaVR, BfB Labs, and Big Health among others are the leading private companies in the digital therapeutics theme.

Leading Companies in the Digital Therapeutics Theme

Leading Companies in the Digital Therapeutics Theme

Buy the Full Report for More Information on the Key Digital Therapeutics Companies, Download a Free Sample Report

Key Highlights

This report consolidates GlobalData’s latest thinking and forecasts around how the healthcare, macroeconomic, technology, and regulatory trends will impact the digital therapeutics market, as well as providing insights into the leading players and future disruptors across the value chain.

The report is designed to provide strategic planners, competitive intelligence professionals and key stakeholders in the pharmaceutical industry a clear view of the opportunities and risks over the foreseeable future for digital therapeutics.

Table of Contents

  • 1 Executive Summary

  • 2 Players

  • 3 Technology Briefing

    • 3.1 DTx are part of the wider digital health technology landscape

  • 4 Trends

    • 4.1 Healthcare trends

    • 4.2 Technology trends

    • 4.3 Macroeconomic trends

    • 4.5 Regulatory trends

  • 5 Market analysis

    • 5.1 DTx by region

      • 5.1.1 DTx cleared for use in the US

      • 5.1.2 DTx reimbursed in Europe

      • 5.1.3 DTx available in APAC

  • 6 Product Profiles

    • 6.1 Cardiovascular

      • 6.1.1 CureApp’s CureApp HT hypertension adjunctive treatment app

      • 6.1.2 My Mhealth’s myCOPD app for COPD self-management

    • 6.2 Central nervous system

      • 6.2.1 Akili’s EndeavorRX for ADHD

      • 6.2.2 Big Health’s Sleepio for insomnia

      • 6.2.3 Big Health’s Daylight for anxiety

      • 6.2.4 GAIA’s Deprexis for depression

      • 6.2.5 GAIA’s Vorvida for alcohol addiction

    • 6.3 Immunology

      • 6.3.1 Sidekick Health’s platform for managing chronic inflammatory illnesses

      • 6.3.2 Ampersand Health’s MyIBD Care mobile app

    • 6.4 Metabolic disorders

      • 6.4.1 DarioHealth’s Dario blood glucose monitoring system for diabetes

      • 6.4.2 Better Health’s AspyreRx for type 2 diabetes

    • 6.5 Musculoskeletal

      • 6.5.1 AppliedVR’s RelieVRx for chronic low back pain

      • 6.5.2 Vivira Health Lab’s ViViRA for knee, hip, and back pain management

    • 6.6 Oncology

      • 6.6.1 Cankado’s CANKADO PRO-React Onco for cancer

      • 6.6.2 Voluntis’s Oleena for cancer patients

    • 6.7 Women’s Health

      • 6.7.1 HelloBetter’s HelloBetter Vaginismus Plus

      • 6.7.2 NaturalCycles’s Natural Cycles mobile app

  • 7 Signals

    • 7.1 Partnerships

    • 7.2 Venture financing

    • 7.3 Mergers and acquisitions

    • 7.4 Hiring trends

    • 7.5 Social media trends

  • 8 Case Studies

    • 8.1 Pear Therapeutics: a lesson for future DTx developers

    • 8.2 AmerisourceBergen is supporting the integration of H2O Therapeutics’s Parky DTx app within healthcare systems

    • 8.3 Axena Health’s Leva Pelvic Health DTx improves the quality of life for women struggling with incontinence

    • 8.4 Ampersand Health has developed digital therapies for long-term inflammatory conditions

    • 8.5 Boehringer Ingelheim and Click Therapeutics partner to treat schizophrenia

  • 9 Value Chain

    • 9.1 Cardiovascular

    • 9.2 Central Nervous System

    • 9.3 Immunology

    • 9.4 Metabolic Disorders

    • 9.5 Musculoskeletal Disorders

    • 9.6 Oncology

    • 9.7 Women’s health

  • 10 Companies

    • 10.1 Public companies

    • 10.2 Private companies

  • 11 Appendix

Frequently asked questions

Digital Therapeutics – Thematic Intelligence thematic reports
Currency USD
$1,950

Can be used by individual purchaser only

Most Popular
$2,925

Can be shared by unlimited users within one corporate location e.g. a regional office

$3,900

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Digital Therapeutics – Thematic Intelligence was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Pharmaceuticals reports
Pharmaceuticals
New
New Drug Approvals and Their Contract Manufacture - 2024 Edition
$4,995 | April 2024
Pharmaceuticals
New
Methicillin-Resistant Staphylococcus aureus (MRSA) Epidemiology Analysis and Forecast to 2033
$3,995 | April 2024
Pharmaceuticals
New
Antibody-Drug Conjugates (ADC) Overview, Industry Trends, Marketed and Pipeline Products,…
$6,995 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Digital Therapeutics – Thematic Intelligence in real time.

  • Access a live Digital Therapeutics – Thematic Intelligence dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more